GALECTO BIOTECH ApS: Financial statements 2018
CVR: 34878366
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2018. In 2018, the company reported a gross profit of EUR -2,569,142 and a net result of EUR -3,659,814 compared with EUR -2,741,160 the year before. Equity in the 2018 report amounted to EUR -12,826,459. The company had 5 employees in the financial year.
- Gross Profit
- EUR -2,569,142
- Profit/Loss
- EUR -3,659,814
- Equity
- EUR -12,826,459
- Total Assets
- EUR 4,410,101
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -2.6 mio. EUR | -3.7 mio. EUR | -12.8 mio. EUR | 5 |
| 2017 | - | -2.1 mio. EUR | -2.7 mio. EUR | -9.2 mio. EUR | 4 |
| 2016 | - | -1.3 mio. EUR | -1.8 mio. EUR | -6.5 mio. EUR | - |
| 2015 | - | 865 t. EUR | -504 t. EUR | -4.6 mio. EUR | - |
| 2014 | - | -15 mio. | -12 mio. | -30.6 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
GALECTO BIOTECH ApS has published its annual report for 2017. Gross profit came to DKK -2,112,610, and the net result was DKK -2,741,160.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.